Systemic Scleroderma clinical trials

Explore recruiting systemic scleroderma clinical trials.

Recruiting systemic scleroderma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Systemic Scleroderma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy and safety of allogenic cultured Adipose-derived mesenchymal stromal cell injections on MoUth fibrosis and handicap in patients with Systemic sclEroderma

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, double-blind, parallel group, placebo-controlled multicenter study to evaluate efficacy, safety and tolerability of ianalumab in participants with diffuse cutaneous systemic sclerosis

France, Greece, Portugal, Hungary, Italy, Germany +4 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase II, multi-part, five-year, randomized, open-label, assessor-blinded, active-controlled, multicenter study to evaluate the efficacy and safety of rapcabtagene autoleucel versus rituximab treatment in participants with severe refractory diffuse cutaneous systemic sclerosis

Italy, Spain, France, Netherlands, Germany, Austria +5 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Systemic Scleroderma trials by city

Systemic Scleroderma in Toronto Systemic Scleroderma in Vancouver Systemic Scleroderma in Montreal Systemic Scleroderma in Calgary Systemic Scleroderma in Edmonton Systemic Scleroderma in Ottawa Systemic Scleroderma in Winnipeg Systemic Scleroderma in Quebec City Systemic Scleroderma in Hamilton Systemic Scleroderma in Kitchener Systemic Scleroderma in London Systemic Scleroderma in Halifax Systemic Scleroderma in New York Systemic Scleroderma in Los Angeles Systemic Scleroderma in Chicago Systemic Scleroderma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease